Turtle Creek Wealth Advisors LLC Has $7.66 Million Position in Cigna Group $CI

Posted by Brian Himes on Jul 3rd, 2026

Turtle Creek Wealth Advisors LLC lifted its position in shares of Cigna Group (NYSE:CI – Free Report) by 58.5% during the 1st quarter, Holdings Channel reports. The firm owned 28,700 shares of the health services provider’s stock after purchasing an additional 10,592 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in Cigna Group were worth $7,656,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Wilkerson Advisory Group LLC acquired a new stake in Cigna Group in the 4th quarter valued at about $25,000. Beacon Financial Strategies CORP acquired a new position in Cigna Group during the fourth quarter worth approximately $28,000. Kemnay Advisory Services Inc. bought a new stake in Cigna Group in the fourth quarter valued at approximately $29,000. Prosperity Bancshares Inc bought a new stake in Cigna Group in the fourth quarter valued at approximately $29,000. Finally, Lodestone Wealth Management LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at approximately $32,000. 86.99% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on CI shares. The Goldman Sachs Group lifted their target price on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their price target for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Sanford C. Bernstein lifted their price objective on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. Mizuho upped their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Finally, Raymond James Financial set a $340.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.

Check Out Our Latest Report on CI

Cigna Group Price Performance

Cigna Group stock opened at $287.50 on Friday. The company has a market capitalization of $76.05 billion, a price-to-earnings ratio of 12.19, a PEG ratio of 1.07 and a beta of 0.29. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12 month low of $239.51 and a 12 month high of $323.10. The stock’s 50 day moving average is $284.84 and its 200-day moving average is $279.18.

Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were issued a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.